Allspring Global Investments Holdings LLC Purchases 15,898 Shares of Owens & Minor, Inc. (NYSE:OMI)

Allspring Global Investments Holdings LLC increased its position in shares of Owens & Minor, Inc. (NYSE:OMI) by 54.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 45,360 shares of the company’s stock after buying an additional 15,898 shares during the period. Allspring Global Investments Holdings LLC owned 0.06% of Owens & Minor worth $410,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC increased its stake in shares of Owens & Minor by 713.4% during the 1st quarter. GAMMA Investing LLC now owns 9,265 shares of the company’s stock worth $84,000 after purchasing an additional 8,126 shares during the last quarter. Parallel Advisors LLC raised its stake in Owens & Minor by 1,387.0% in the first quarter. Parallel Advisors LLC now owns 3,316 shares of the company’s stock valued at $30,000 after buying an additional 3,093 shares during the period. Versant Capital Management Inc lifted its position in shares of Owens & Minor by 537.6% in the first quarter. Versant Capital Management Inc now owns 3,201 shares of the company’s stock valued at $29,000 after buying an additional 2,699 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Owens & Minor by 29.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 219,761 shares of the company’s stock valued at $2,872,000 after buying an additional 50,184 shares during the last quarter. Finally, Voloridge Investment Management LLC lifted its position in shares of Owens & Minor by 24.2% in the fourth quarter. Voloridge Investment Management LLC now owns 243,525 shares of the company’s stock valued at $3,183,000 after buying an additional 47,459 shares during the last quarter. 98.04% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages have issued reports on OMI. Citigroup cut their price target on Owens & Minor from $13.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, April 17th. Robert W. Baird raised their price target on Owens & Minor from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Friday, June 6th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $11.60.

Owens & Minor Trading Down 4.1%

Shares of Owens & Minor stock opened at $8.28 on Friday. The business has a fifty day simple moving average of $7.63 and a two-hundred day simple moving average of $9.14. Owens & Minor, Inc. has a 1 year low of $6.07 and a 1 year high of $16.98. The company has a market capitalization of $639.63 million, a price-to-earnings ratio of -1.74, a P/E/G ratio of 0.38 and a beta of 1.40. The company has a debt-to-equity ratio of 3.32, a current ratio of 1.13 and a quick ratio of 0.41.

Owens & Minor (NYSE:OMI) last posted its quarterly earnings data on Saturday, May 10th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.03. Owens & Minor had a positive return on equity of 17.09% and a negative net margin of 3.41%. The firm’s revenue for the quarter was up .7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.19 EPS. Research analysts forecast that Owens & Minor, Inc. will post 1.51 EPS for the current year.

Owens & Minor Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.